Acrokeratosis neoplastica

Author: Vanessa Ngan, staff writer, 2004.

What is acrokeratosis neoplastica?

Acrokeratosis neoplastica is a rare skin condition with features rather like psoriasis. It is more often than not associated with squamous cell carcinoma of the upper respiratory or gastrointestinal tract. It is far more common in males than females.

Acrokeratosis neoplastica is also known as ‘paraneoplastic acrokeratosis’ and ‘Bazex syndrome’ – but is quite different from the genetic syndrome also called ‘Bazex syndrome’, in which there are many basal cell carcinomas.

What are the clinical features of acrokeratosis neoplastica? 

Acrokeratosis neoplastica usually begins with scaling dermatosis of the fingers and toes that may quickly spread to the nails. Onset is sometimes quite gradual. Cutaneous features include:

Patients may have weight loss, fatigue, general malaise, and other non-specific symptoms that point towards internal malignancy.

What is the cause of acrokeratosis neoplastica?

Most cases of acrokeratosis neoplastica are due to an internal cancer. The cancer is usually a squamous cell carcinoma of the upper respiratory tract or the upper gastrointestinal tract (oral cavity, pharynx, larynx, oesophagus). At diagnosis the lymph nodes are usually already involved.

Other cancers that have been found with acrokeratosis neoplastica include squamous cell carcinoma of the thymus and vulva, anaplastic small cell carcinoma of the lung and adenocarcinoma of the uterus.

The signs and symptoms of acrokeratosis neoplastica suggest the presence of circulating antibodies to tumour antigens. The chemical messengers, cytokines, that are released by skin and immune cells, may also play a role.

What is the treatment for acrokeratosis neoplastica?

Patients with acrokeratosis neoplastica need to undergo thorough medical and physical examination, and appropriate blood tests and X-rays to check for cancer. Acrokeratosis neoplastica may resolve if the underlying cancer is completely removed and return of the condition may indicate relapse of the underlying cancer.

Topical corticosteroids and emollient creams containing urea, lactic acid or salicylic acid, may reduce the thickness and irritation of the scaly skin lesions. Therapy with a type of vitamin D, cholecalciferol, or calcipotriol cream, has also been reported to be of benefit. Oral retinoids such as acitretin may help the cutaneous features.

Related information

Make a donation

Donate Today!